https://orcid.org/0000-0002-8563-6395
References
- Wang L, Qu Z, Sun Q, Mao Z, Si P, Wang W. 4-hydroxysesamin, a modified natural compound, attenuates neuronal apoptosis after ischemic stroke via inhibiting MAPK pathway. Neuropsy Dis Treat. 2024;20:523–533 doi:10.2147/NDT.S444760.
- Dalibalta S, Majdalawieh AF, Manjikian H. Health benefits of sesamin on cardiovascular disease and its associated risk factors. Saudi Pharm J. 2020;28(10):1276–1289. doi:10.1016/j.jsps.2020.08.018
- Rosalina R, Weerapreeyakul N. An insight into sesamolin: physicochemical properties, pharmacological activities, and future research prospects. Molecules. 2021;26(19):5849. doi:10.3390/molecules26195849
- Holloway PM, Gavins FN. Modeling ischemic stroke in vitro: status quo and future perspectives. Stroke. 2016;47(2):561–569. doi:10.1161/STROKEAHA.115.011932
- Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review). Int J Mol Med. 2022;49(2):15. doi:10.3892/ijmm.2021.5070